Musculoskeletal Embolotherapy
- PMID: 36352126
- DOI: 10.1007/s00270-022-03302-z
Musculoskeletal Embolotherapy
Abstract
Painful articular musculoskeletal (MSK) conditions are common, debilitating and sometimes difficult to treat. Transcatheter embolisation may offer an alternative way to manage the pain associated with these conditions, but the field is still in its infancy. To date, the most commonly studied indication is knee osteoarthritis, but the technique has been trailed in multiple other tissue beds, including for adhesive capsulitis and tendinopathies. Whilst early results appear promising, the existing studies are mostly open-labelled and non-randomised; there is a need for high-quality evidence to robustly assess the procedures efficacy. In this review, we set out to evaluate the current evidence underlying the pathophysiology and mechanism of action of embolisation; discuss the technical aspects of the procedure including embolic selection, and appraise the published clinical outcomes and adverse effects. Finally, we discuss the future directions and research priorities in this rapidly developing field.
Keywords: Embolisation; Joints; Musculoskeletal.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
References
-
- United States Bone and Joint Initiative, The burden of musculoskeletal diseases in the United States, Fourth edition. Available at www.boneandjointburden.org . Accessed on 07/06/2022, 2020.
-
- Versus Arthritis, The State of Musculoskeletal Health 2021: Arthritis and other musculoskeletal conditions in numbers. Available at www.versusarthritis.org/media/24653/state-of-msk-health2-2021.pdf Accessed on 07/06/2022, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical